Search research articles
Contact Us
Filters
Showing results (61-70 of 123) with videos related to
Page
of 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 13, 2023
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial
Birgit Geoerger, Lynley V Marshall, Karsten Nysom, et al.
JAMA Ophthalmology
|
June 20, 2020
Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma
Flore Salviat, Marion Gauthier-Villars, Matthieu Carton, et al.
Eclinicalmedicine
|
February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution
Allison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 23, 2021
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium
Claudia Pasqualini, Jonathan Rubino, Caroline Brard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 20, 2021
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial
Raphael J Morscher, Caroline Brard, Pablo Berlanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2021
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
Francisco Bautista, Xavier Paoletti, Jonathan Rubino, et al.
Nature Communications
|
November 6, 2023
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Jill Pilet, Theo Z Hirsch, Barkha Gupta, et al.
Journal of Pediatric Hematology/Oncology
|
February 17, 2025
PHOX2B -associated Congenital Central Hypoventilation Syndrome Revealed Upon Treatment With Dinutuximab-beta
Alix Chupin, Benjamin Dudoignon, Nathalie Couque, et al.
Archives of Disease in Childhood
|
November 26, 2018
Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study
Agathe Béranger, Naïm Bouazza, Amélie de Haut de Sigy, et al.
The Journal of Molecular Diagnostics : JMD
|
October 17, 2021
Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers
Jessica Le Gall, Catherine Dehainault, Camille Benoist, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 123) with videos related to
Sort By:
Page
of 13
European Journal of Cancer (Oxford, England : 1990)
|
May 13, 2023
Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial
Birgit Geoerger, Lynley V Marshall, Karsten Nysom, et al.
JAMA Ophthalmology
|
June 20, 2020
Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma
Flore Salviat, Marion Gauthier-Villars, Matthieu Carton, et al.
Eclinicalmedicine
|
February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution
Allison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 23, 2021
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium
Claudia Pasqualini, Jonathan Rubino, Caroline Brard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 20, 2021
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial
Raphael J Morscher, Caroline Brard, Pablo Berlanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2021
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
Francisco Bautista, Xavier Paoletti, Jonathan Rubino, et al.
Nature Communications
|
November 6, 2023
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Jill Pilet, Theo Z Hirsch, Barkha Gupta, et al.
Journal of Pediatric Hematology/Oncology
|
February 17, 2025
PHOX2B -associated Congenital Central Hypoventilation Syndrome Revealed Upon Treatment With Dinutuximab-beta
Alix Chupin, Benjamin Dudoignon, Nathalie Couque, et al.
Archives of Disease in Childhood
|
November 26, 2018
Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study
Agathe Béranger, Naïm Bouazza, Amélie de Haut de Sigy, et al.
The Journal of Molecular Diagnostics : JMD
|
October 17, 2021
Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers
Jessica Le Gall, Catherine Dehainault, Camille Benoist, et al.
Page
of 13